Medical AI Alliance
← Company Index
Biotech & Drug DiscoveryKOSDAQ 35420012 approvals

NGeneBio Co., Ltd.

Official website

KOSDAQ-listed precision-diagnostics company manufacturing genomic diagnostic reagents and developing related software.

As of 2026-10-11, NGeneBio Co., Ltd. has 12 Korean MFDS device approvals, 13 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2015 and listed on KOSDAQ in 2020, NGeneBio is a precision-diagnostics company. It manufactures genomic diagnostic reagents. It also engages in the research, development, and sale of genomic software.

Products & technology

  • Genomic diagnostic reagentsGenomic-based precision diagnostics

Regulatory approvals

data.go.kr

12 Korean MFDS device approvals · 2017–2025

  • MFDSIVD reagents for cancer related gene2025-03-28
    Product approval · Class 3체외 제허 25-197 호
  • MFDSIVD reagents for cancer related gene2025-02-25
    Product approval · Class 3체외 제허 25-112 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2022-06-22
    Product approval · Class 3체외 제허 22-407 호
  • MFDSIVD reagents for cancer related gene2021-08-23
    Product approval · Class 3체외 제허 21-706 호
  • MFDSIVD reagents for histocompatibility antigen, antibody for transfusion or transplantation, molecular diagnostics2021-06-09
    Product approval · Class 3체외 제허 21-461 호
  • MFDSIVD reagents for histocompatibility antigen, antibody for transfusion or transplantation, molecular diagnosticsRevoked2021-05-10
    Product approval · Class 3체외 제허 21-361 호
  • MFDSIVD reagents for cancer related gene2021-04-05
    Product approval · Class 3체외 제허 21-253 호
  • MFDSIVD reagents for cancer related geneRevoked2021-03-02
    Product approval · Class 3체외 제허 21-160 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2020-08-14
    Product approval · Class 3체외 제허 20-662 호
  • MFDSIVD reagents for cancer related gene2020-05-28
    Product approval · Class 3체외 제허 20-398 호
  • MFDSIVD reagents for cancer related gene2020-05-28
    Product approval · Class 3체외 제허 20-397 호
  • MFDSIVD reagents for cancer related geneRevoked2017-12-26
    Product approval · Class 3체외 제허 17-983 호

Key disclosures

KRX KIND via OpenDART
Show 12 more events

Publications

PubMed · affiliation-matched
Show 3 more publications

Patents

KIPRIS · applicant-matched
Show 34 more patents

AI reads

MAA server logs · IP-verified
29
Times AI engines pulled NGeneBio Co., Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

1
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

28
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

7
live 0
Last 7 days
20
live 1
Last 30 days
29
live 1
All time
  • OpenAIChatGPT-Userlive1
  • OpenAIOAI-SearchBot18
  • GoogleGoogleOther4
  • PerplexityPerplexityBot3
  • AnthropicClaudeBot2
  • MicrosoftBingbot1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for NGeneBio Co., Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsBiotech & Drug Discovery

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

Gencurix Inc.2 shared

Founded 2011, KOSDAQ-listed 2020, Gencurix develops liquid-biopsy diagnostics: breast cancer prognosis and lung/colorectal companion tests.

OSANG HEALTHCARE CO.,LTD.2 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

BIONEERCORPORATION2 shared

Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.

HLB PANAGENE Co., LTD.2 shared

Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.

Optipharm.CO.,LTD2 shared

Optipharm, founded in 2000 and KOSDAQ-listed in 2018, provides animal disease diagnostics, animal medicine, and biotech.

GC Medical Science Corporation2 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

LabGenomics. Co., Ltd.2 shared

KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.

SEEGENE, INC.2 shared

Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.

Genomictree Inc.2 shared

Cancer molecular diagnostics company behind the EarlyTect-C stool-based colorectal cancer test using the SDC2 methylation biomarker.

RollingStone Co., Ltd.1 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

GENEMATRIX INC.1 shared

KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.

GENOTECH CORP.1 shared

Supplies synthetic genes (GenOligo) and DNA sequencing analysis services for biotech research.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition